That’s because the nation’s largest trade group for medical doctors is conducting a practice survey that could have big implications for physician payment.

The ratings agency dropped Akumin from "CCC" to "D," the lowest mark on S&P’s scale, typically used after a company files such a petition. 

The nearly half-billion-dollar loan balance will convert to shares of common stock, held by lender Stonepeak, with Akumin transitioning to a privately held company. 

Adding MSDR will allow AMN to provide a larger candidate pool, including professionals specializing in some of the “most needed, in-demand services.” 

Vuno's DeepBrain is intended to automate the manual process of identifying, labeling and quantifying brain structures from MRIs. 

Payers most frequently require PA for imaging (71%), followed by IV chemotherapy, surgery and radiotherapy, according to new survey data. 

Such behavior can lead to "increased stress and job dissatisfaction, at the expense of well-being of breast radiologists,” MD Anderson experts wrote in Clinical Imaging. 

Through the end of July, 79% of all AI products authorized by the agency in 2023 are in radiology, followed by 9% in cardiovascular care, and 5% in neurology. 

The pause will last until Akumin can restore its systems in a “safe and secure manner,” leaving the company unable to see patients at its fixed-site locations. 

This year alone, ACR has tracked more than 100 proposed policies relating to radiologic scope-of-practice expansion, spanning 30 states.